These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8772594)
1. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898 [TBL] [Abstract][Full Text] [Related]
3. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085 [TBL] [Abstract][Full Text] [Related]
5. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Sy RA; Bernstein R; Chynn KY; Kourides IA J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506 [TBL] [Abstract][Full Text] [Related]
6. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide. Fischler MP; Reinhart WH J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139 [TBL] [Abstract][Full Text] [Related]
7. Octreotide changes serum thyrotropin (TSH) glycoisomer distribution as assessed by lectin chromatography in a TSH macroadenoma patient. Francis TB; Smallridge RC; Kane J; Magner JA J Clin Endocrinol Metab; 1993 Jul; 77(1):183-7. PubMed ID: 8325941 [TBL] [Abstract][Full Text] [Related]
8. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. Caron P; Buscail L; Beckers A; Estève JP; Igout A; Hennen G; Susini C J Clin Endocrinol Metab; 1997 Nov; 82(11):3771-6. PubMed ID: 9360539 [TBL] [Abstract][Full Text] [Related]
9. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. Mozas J; Ocón E; López de la Torre M; Suárez AM; Miranda JA; Herruzo AJ Int J Gynaecol Obstet; 1999 Apr; 65(1):71-3. PubMed ID: 10390105 [TBL] [Abstract][Full Text] [Related]
10. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Blackhurst G; Strachan MW; Collie D; Gregor A; Statham PF; Seckl JE Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834 [TBL] [Abstract][Full Text] [Related]
11. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge. Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380 [TBL] [Abstract][Full Text] [Related]
12. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs. Rabbiosi S; Peroni E; Tronconi GM; Chiumello G; Losa M; Weber G Thyroid; 2012 Oct; 22(10):1076-9. PubMed ID: 22947349 [TBL] [Abstract][Full Text] [Related]
13. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma]. Chen S; Li M; Lian XL; Zeng ZP; Dai WX; Li F; Yu W; Wang RZ Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878 [TBL] [Abstract][Full Text] [Related]
14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients. Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412 [TBL] [Abstract][Full Text] [Related]
15. Management of a pregnant woman with thyrotropinoma: a case report and review of the literature. Perdomo CM; Árabe JA; Idoate MÁ; Galofré JC Gynecol Endocrinol; 2017 Mar; 33(3):188-192. PubMed ID: 27910710 [TBL] [Abstract][Full Text] [Related]
17. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma. Wémeau JL; Dewailly D; Leroy R; D'Herbomez M; Mazzuca M; Decoulx M; Jaquet P J Clin Endocrinol Metab; 1988 Mar; 66(3):636-9. PubMed ID: 2895119 [TBL] [Abstract][Full Text] [Related]
18. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases. Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054 [TBL] [Abstract][Full Text] [Related]
19. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Lee EJ; Kim KR; Lim SK; Lee HC; Kim DI; Kim SH; Huh KB Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902 [TBL] [Abstract][Full Text] [Related]